NRSN
Neurosense TherapeuticsFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
NRSN vs peer average
28/100
NRSN vs. peer average (F vs. D)
Grade spread
A 2 · B 1 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked
Peer overview
CRVO is the first available peer comparator.
Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $27.78M
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
NRSN
Neurosense Therapeutics
CRVO
CervoMed
Grade
F
F
Momentum
11
12
Value
44
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Grade position vs CRVO
NRSN / CRVO
Grade Position
Below peers
NRSN vs. peer average (F vs. D)
28/100
Momentum
11
CRVOValue
44
NRSNSentiment
-
-Rotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs NRSN
CRVO is the first peer returned for this comparison set.

